These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17617567)

  • 1. The CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell death.
    Thorén FB; Romero AI; Hermodsson S; Hellstrand K
    J Immunol; 2007 Jul; 179(2):781-5. PubMed ID: 17617567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.
    Harlin H; Hanson M; Johansson CC; Sakurai D; Poschke I; Norell H; Malmberg KJ; Kiessling R
    J Immunol; 2007 Oct; 179(7):4513-9. PubMed ID: 17878347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
    Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
    Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
    Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
    J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.
    Lutz CT; Karapetyan A; Al-Attar A; Shelton BJ; Holt KJ; Tucker JH; Presnell SR
    J Immunol; 2011 Apr; 186(8):4590-8. PubMed ID: 21402893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of human natural killer-cell subsets.
    Cooper MA; Fehniger TA; Caligiuri MA
    Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD56bright natural killer (NK) cells: an important NK cell subset.
    Poli A; Michel T; Thérésine M; Andrès E; Hentges F; Zimmer J
    Immunology; 2009 Apr; 126(4):458-65. PubMed ID: 19278419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of CD3
    Tahrali I; Kucuksezer UC; Altintas A; Uygunoglu U; Akdeniz N; Aktas-Cetin E; Deniz G
    Clin Immunol; 2018 Aug; 193():88-97. PubMed ID: 29448007
    [No Abstract]   [Full Text] [Related]  

  • 11. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
    Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
    J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.
    Koo KC; Shim DH; Yang CM; Lee SB; Kim SM; Shin TY; Kim KH; Yoon HG; Rha KH; Lee JM; Hong SJ
    PLoS One; 2013; 8(11):e78049. PubMed ID: 24223759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune potential of decidua-resident CD16
    Zhang J; Lye SJ
    Hum Immunol; 2021 May; 82(5):332-339. PubMed ID: 33583640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating NK cells and their subsets in Behçet's disease.
    Hasan MS; Ryan PL; Bergmeier LA; Fortune F
    Clin Exp Immunol; 2017 May; 188(2):311-322. PubMed ID: 28170096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56
    Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
    J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H₂O₂ production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction.
    Izawa S; Kono K; Mimura K; Kawaguchi Y; Watanabe M; Maruyama T; Fujii H
    Cancer Immunol Immunother; 2011 Dec; 60(12):1801-10. PubMed ID: 21811786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
    Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
    J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance between peripheral and decidual NK cell subsets and killer immunoglobulin-like receptors in women with recurrent spontaneous miscarriages.
    El-Badawy O; Helmy AS; Abbas AM; Zahran AM; Afifi NA; Abdel-Rahim MH
    J Reprod Immunol; 2020 Aug; 140():103130. PubMed ID: 32330774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.
    Keating SE; Zaiatz-Bittencourt V; Loftus RM; Keane C; Brennan K; Finlay DK; Gardiner CM
    J Immunol; 2016 Mar; 196(6):2552-60. PubMed ID: 26873994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.